Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Healthcare Plans

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Revenue projections:

Revenue projections for CI
Revenue projections for CI

CI's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.849000
forwardPE 8.688712
debtToEquity 75.137000
earningsGrowth -0.093000
revenueGrowth 0.104000
grossMargins 0.092980
operatingMargins 0.035300
trailingEps 22.190000
forwardEps 33.474470

CI's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins.
The Cigna Group's negative gross and operating margins indicate that the company is operating at a loss. This reflects an inability to cover production costs and operational expenses, which could undermine its financial stability.
The Cigna Group's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that The Cigna Group's financial performance will improve in the current financial year.

Price projections:

Price projections for CI
Price projections for CI

Price projections for The Cigna Group have been revised lower over time, signaling a more cautious outlook from analysts. The gradual downward trend indicates that expectations for the company's growth may be softening.

Insider Transactions:

Insider Transactions for CI
Insider Transactions for CI


Recent trading of CI stock saw 5 sales, with market price at 310.6579956054687 per share.There were 1 transactions to buy CI stock, with market price of 258.6199951171875.The trend of more buys compared to sells around CI's current price levels may signal investor optimism. This behavior suggests that the market is expecting a favorable outcome for the stock, leading to increased buying activity.

Recommendation changes over time:

Recommendations trend for CI
Recommendations trend for CI


Analysts have been favoring The Cigna Group with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning The Cigna Group as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.